SCHEMBL1495175

SCHEMBL1495175

CCCCCc1ccccc1NN

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 1/20 0.50
▸ POLB P06746 1/20 0.42
▸ TLR8 Q9NR97 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ NR1H2 P55055 1/20 0.41
▸ NR1H3 Q13133 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ HTR2A P28223 1/20 0.40
▸ CYSLTR2 Q9NS75 1/20 0.39
▸ CYSLTR1 Q9Y271 1/20 0.39
▸ SLC16A3 O15427 1/20 0.39
▸ BID P55957 3/20 0.39
▸ MCL1 Q07820 3/20 0.39
▸ BCL2L1 Q07817 2/20 0.39
▸ BAK1 Q16611 2/20 0.39
▸ KAT8 Q9H7Z6 2/20 0.39
▸ PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28282712 0.98 LIPG (0.49) LIPGPOLBTLR8ALDH1A1GAA
SCHEMBL29573161 0.94 POLB (0.44) LIPGPOLBTLR8ALDH1A1GAA
SCHEMBL7446162 0.94 POLB (0.44) LIPGPOLBTLR8ALDH1A1GAA
Hydrochloric Acid SCHEMBL1723028 0.92 POLB (0.42) LIPGPOLBTLR8ALDH1A1GAA
SCHEMBL6938190 0.87 F7 (0.44) LIPGMAPTBIDMCL1BCL2L1
SCHEMBL7438728 0.86 ALDH1A1 (0.46) POLBALDH1A1GAAMAPT
Hydrochloric Acid SCHEMBL4915526 0.84 ALDH1A1 (0.44) POLBALDH1A1GAAMAPT
SCHEMBL14785526 0.82 LIPG (0.56) LIPGNR1H2NR1H3ALOX5PTGS2
SCHEMBL31139998 0.82 LIPG (0.56) LIPGNR1H2NR1H3ALOX5PTGS2
SCHEMBL9418574 0.82 LIPG (0.56) LIPGNR1H2NR1H3ALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894326-A 2,3-hydrogen substituted aminoindole derivative, preparation method and application thereof 佛山科学技术学院 2023-04-04 — — CN claimed
CN-109467528-B Synthesis method of 1-aminoindole derivative 佛山科学技术学院 2020-11-06 — — CN claimed
CN-115894326-A 2,3-hydrogen substituted aminoindole derivative, preparation method and application thereof 佛山科学技术学院 2023-04-04 — — CN disclosed
CN-109467528-B Synthesis method of 1-aminoindole derivative 佛山科学技术学院 2020-11-06 — — CN disclosed
US-20110077410-A1 Process for the Preparation of 1-Phenyl-1,2,4-triazoles BAYER CROPSCIENCE AG (DE) 2011-03-31 — — US disclosed
CN-1151155-C 1, 5-dihydro-pyrazolo [3, 4-D ] -pyrimidone derivatives — 2004-05-26 — — CN disclosed
EP-0694808-B1 Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor DAINIPPON INK & CHEMICALS (JP) 2001-12-05 — — EP disclosed
CN-1255133-A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives BAYER AG (DE) 2000-05-31 — — CN disclosed
US-5856495-A Process for the preparation of triazolinone herbicides DEGUSSA AKTIENGESELLSCHAFT (DE) 1999-01-05 — — US disclosed
US-5766833-A CONTAINS A REDUCTONE AS A MAIN DEVELOPING AGENT IN THE PRESENCE OF A 1,2,5-THIADIAZOLE AND/OR A 2,1,3-BENZOTHIADIAZOLE DAINIPPON INK AND CHEMICALS INC. (JP) 1998-06-16 — — US disclosed
EP-0518352-B1 Process for forming super high-contrast negative images and silver halide photographic material and developer being used therefor DAINIPPON INK & CHEMICALS (JP) 1998-04-22 — — EP disclosed
EP-0283040-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1988-09-21 — — EP disclosed
US-4767692-A NUCLEATING AGENT WITH UREA AND HYDRAZIDE GROUPS FUJI PHOTO FILM CO., LTD. (JP) 1988-08-30 — — US disclosed
EP-0190512-A2 Positive image forming method KONICA CORPORATION (JP) 1986-08-13 — — EP disclosed
US-4550070-A Direct positive silver halide photographic light-sensitive materials FUJI PHOTO FILM CO., LTD. (JP) 1985-10-29 — — US disclosed
US-4160862-A ANTIINFLAMMATORY STERLING DRUG INC. (US) 1979-07-10 — — US disclosed
US-4160862-A ANTIINFLAMMATORY STERLING DRUG INC. (US) 1979-07-10 — — US disclosed
US-4075218-A INSECTICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1978-02-21 — — US disclosed
US-4021431-A ANTIINFLAMMATORY AGENTS STERLING DRUG INC. (US) 1977-05-03 — — US disclosed
US-4021431-A ANTIINFLAMMATORY AGENTS STERLING DRUG INC. (US) 1977-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077410-A1 Process for the Preparation of 1-Phenyl-1,2,4-triazoles CYP4B1, PAH, CYP3A4 LIPG 4797/4885POLB 2063/4885TLR8 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback